Pre-earnings options volume in Prokidney (PROK) Corp is normal with calls leading puts 12:1. Implied volatility suggests the market is anticipating a move near 13.0%, or 35c, after results are released. Median move over the past eight quarters is 2.6%.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROK:
- Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment
- Largest borrow rate increases among liquid names
- ProKidney’s Hold Rating: Balancing FDA Alignment and Extended Approval Timeline
- ProKidney’s Clinical Trials and Regulatory Developments Lead to Hold Rating Amid Uncertainty
- ProKidney’s Strategic FDA Alignment and Promising Clinical Data Drive Buy Rating